John D. Pavlidis, who has more than 25 years of technical and executive management experience in the medical industry, has joined Volpara Solutions’ Board of Directors.
Currently serving on the Boards of Directors for Clario Medical and DySIS Medical, Pavlidis has previously served on the board for breast ultrasound screening firm U-Systems, which was acquired by GE Healthcare in 2012. Most recently, Pavlidis was president and CEO of cardiac device maker Estech, until the company was acquired by AtriCure in 2013. He has also served as president and CEO of R2 Technology, leading the company through a successful acquisition by Hologic. Furthermore, Pavlidis previously worked in Siemens’ MR and CT divisions before serving as president of its global Ultrasound Division.
“Throughout my career, my goal has always been to improve health and well-being by helping high quality medical device companies succeed,” Pavlidis said. “I am honored to be joining Volpara Solutions to help this highly accomplished team drive adoption of its industry-leading breast imaging density and quantitative breast imaging tools that are rapidly becoming the industry gold standard.”
“We are pleased to add John’s extensive expertise and proven track record for implementing on a clear strategic vision in a supportive, cohesive environment,” said Ralph Highnam, chief executive and co-founder of Volpara Solutions.
Volpara Solutions is the creator of the algorithm behind VolparaDensity, designed to provide an objectively volumetric measure of breast density from both digital mammography and tomosynthesis images.
Get AXIS e-newsletters free. Subscribe here.
